ANNOVIS BIO (ANVS) Stock Income Statement
NYSE:ANVS - US03615A1088 - Common Stock
2.43 USD
+0.19 (+8.48%)
2.48 USD
+0.05 (+2.06%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 23.68M | 26.69M | 45.03M | 25.51M | 14.54M | |||
| Research and Development | 17.86M | 20.00M | 38.79M | 16.52M | 8.48M | |||
| Selling, General, and Administrative Expenses | 5.82M | 6.70M | 6.24M | 9.00M | 6.06M | |||
| Operating Income | -23.68M | -26.69M | -45.03M | -25.51M | -14.54M | |||
| Interest Income/Expense | 640.70K | 331.90K | 667.90K | 180.00K | 10.00K | |||
| Other Income/Expense | -7.22M | 1.77M | -11.84M | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | 40.00K | |||
| Income Before Taxes | -30.26M | -24.59M | -56.20M | -25.33M | -14.49M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | 0.00 | |||
| Net Income | -30.26M | -24.59M | -56.20M | -25.33M | -14.49M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.01 | -2.02 | -6.23 | -3.10 | -1.90 | |||
| Non GAAP EPS | -2.04 | -1.82 | -6.13 | -3.10 | -1.90 | |||
| Statistics | ||||||||
All data in USD